Benzinga's Top Upgrades

Analysts at Credit Suisse upgraded USG USG from “underperform” to “neutral.” The target price for USG has been raised from $22 to $27. USG's stock closed at $24.55 on Friday. Analysts at Compass Point upgraded First Horizon National FHN from “sell” to “neutral.” The target price for First Horizon National has been raised from $9.50 to $10. First Horizon National's shares closed at $9.90 on Friday. JP Morgan upgraded Perrigo Company PRGO from “neutral” to “overweight.” The target price for Perrigo has been raised from $120 to $132. Perrigo's shares closed at $119.47 on Friday. Morgan Stanley upgraded AbbVie ABBV from “equal weight” to “overweight.” The target price for AbbVie has been raised from $36 to $49. AbbVie's shares closed at $42.39 on Friday.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
date
ticker
name
Price Target
Upside/Downside
Recommendation
Firm
Posted In: UpgradesAnalyst Ratingstop upgrades
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!